Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
190.00
Ask:
198.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Acquisition and Admission

4 Dec 2008 07:00

RNS Number : 5152J
Garner PLC
04 December 2008
 



4 December 2008

Garner Plc

("Garner" or the "Company")

Completion of Acquisition

Change of Chairman

Cancellation of Trading in the Company's Preference Shares

Admission of Ordinary Shares to Trading on AIM

Further to the announcement yesterday and following the passing on 2 December 2008 of the resolutions at a general meeting of the Company's shareholders and a class meeting of the Company's preference shareholders, the Company is pleased to announced the completion of the acquisition of the NB Companies and the admission to trading of the enlarged share capital of the Company to AIM.

The enlarged group now has a total of 34 consultants and over 100 clients, including 14 in the FTSE 250. The Directors believe that it is now one of the largest providers of executive search in the UK.

As set out in the circular to shareholders dated 7 November 2008 (the "Circular"), John Bartle has stepped down as Chairman of the Company but is remaining on the board as the senior non-executive director. Andrew Garner has been appointed Executive Chairman and Sue O'Brien has been made Managing Director of the Company. 

The Company's preference shares have now all been converted into ordinary shares, as set out in the Circular, and trading in the preference shares on AIM has been cancelled.

A total of 32,702,863 ordinary shares of 1 pence each have been issued in respect of the placing and the conversion of the preference shares and the Company's issued share capital is now 70,855,541 ordinary shares of 1 pence each. Admission of the Company's shares is now effective and trading will begin at 8.00am today, December 2008. 

The interests of the Directors and of the significant shareholders in the Company are set out below:

Director

Number of Ordinary Shares

Percentage of Issued Share Capital

Andrew Garner

15,571,707

21.98%

Richard Robinson

5,053,019

7.13%

Sue O'Brien

1,295,238

1.83%

Bruce Lakefield

2,436,667

3.44%

John Bartle

8,810,487

12.43%

Significant Shareholders

Charles Auld

5,000,000

7.06%

Roy Stanley

4,300,000

6.07%

Jagdish Sharma

3,797,000

5.36%

For further information please contact:

Garner plc: 

Andrew Garner, Executive Chairman

Caroline Mallin, Communications Director

Tel: 020 7629 8822

Dowgate Capital Advisers Limited: 

James Caithie

Antony Legge

Tel: 020 7492 4777

St Helen's Capital Plc:

Ruari McGirr

Mark Anwyl

Tel: 020 7628 5582

Web site: www.garnerinternational.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDXLFBVLBEFBQ
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.